Status:
ENROLLING_BY_INVITATION
Surgical Treatment of the Patients With Restrictive Phenotype of the Hypertrophic Cardiomyopathy Without LVOT Obstruction
Lead Sponsor:
Petrovsky National Research Centre of Surgery
Conditions:
Apical Hypertrophic Cardiomyopathy
Eligibility:
All Genders
15+ years
Brief Summary
Hypertrophic cardiomyopathy - is an inherited disease characterized by pronounced genetic and phenotypic heterogeneity. There are two most common anatomic variants of cardiac hypertrophy: subaortic an...
Eligibility Criteria
Inclusion
- Hypertrophic apical cardiomyopathy according to medical records
- Surgical left ventricular remodeling performed
Exclusion
- LVOT gradient greater than 30 mmHg
Key Trial Info
Start Date :
June 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06977646
Start Date
June 1 2025
End Date
December 1 2025
Last Update
July 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Petrovsky National Research Centre of Surgery
Moscow, Moscow, Russia, 119991